From GlobeNewswire: 2024-06-13 16:00:00

The Global Softgel Capsule Market is projected to grow from USD 1.25 billion in 2023 to USD 2.30 billion by 2033, at a CAGR of 6.29%. Gelatin-based soft gel capsules offer benefits such as enhanced availability and better absorption. Manufacturers are focused on improving technology and materials to offer more advantages like tamper-evident features and controlled release.

The gelatin softgel capsules segment dominates the market, offering benefits such as ease of digestion and patient compliance. Pharmaceutical companies are driving growth in the market with their R&D capabilities. The health supplements segment leads in revenue share due to increased use of softgel capsules for dietary supplements.

North America holds the largest market share in the global softgel capsule market, supported by a strong healthcare infrastructure. Asia Pacific is expected to grow at the fastest rate due to the region’s growing pharmaceutical industry and low manufacturing costs. Major vendors in the market include renowned companies like Catalent, Inc., and Lonza Capsules & Health Ingredients.

Recent developments include Amneal Pharmaceuticals and Strides Pharma Science Limited launching Icosapent ethyl acid soft gel capsules. The global softgel capsule market is segmented by type, manufacturers, application, and region. Key regions covered in the report include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Major market segments are gelatin capsules, non-gelatin softgel capsules, pharmaceutical companies, and health supplements.



Read more at GlobeNewswire: Global Softgel Capsule Market Size To Worth USD 2.30